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Mutation in PNPT1, which Encodes a Polyribonucleotide
Nucleotidyltransferase, Impairs RNA Import into
Mitochondria and Causes Respiratory-Chain Deficiency
Vanessa Vedrenne,1,6 Ali Gowher,2,6 Pascale De Lonlay,3 Patrick Nitschke,4 Vale´rie Serre,1
Nathalie Boddaert,3 Cecilia Altuzarra,5 Anne-Marie Mager-Heckel,2 Florence Chretien,1 Nina Entelis,2
Arnold Munnich,1,3 Ivan Tarassov,2 and Agne`s Ro¨tig1,*
Multiple-respiratory-chain deficiency represents an important cause of mitochondrial disorders. Hitherto, however, mutations in genes
involved in mtDNA maintenance and translation machinery only account for a fraction of cases. Exome sequencing in two siblings,
born to consanguineous parents, with severe encephalomyopathy, choreoathetotic movements, and combined respiratory-chain
defects allowed us to identify a homozygous PNPT1 missense mutation (c.1160A>G) that encodes the mitochondrial polynucleotide
phosphorylase (PNPase). Blue-native polyacrylamide gel electrophoresis showed that no PNPase complex could be detected in subject
fibroblasts, confirming that the substitution encoded by c.1160A>G disrupts the trimerization of the protein. PNPase is predominantly
localized in the mitochondrial intermembrane space and is implicated in RNA targeting to human mitochondria. Mammalian
mitochondria import several small noncoding nuclear RNAs (5S rRNA, MRP RNA, some tRNAs, and miRNAs). By RNA hybridization
experiments, we observed a significant decrease in 5S rRNA and MRP-related RNA import into mitochondria in fibroblasts of affected
subject 1. Moreover, we found a reproducible decrease in the rate of mitochondrial translation in her fibroblasts. Finally, overexpression
of the wild-type PNPT1 cDNA in fibroblasts of subject 1 induced an increase in 5S rRNA import in mitochondria and rescued
the mitochondrial-translation deficiency. In conclusion, we report here abnormal RNA import into mitochondria as a cause of
respiratory-chain deficiency.Mitochondrial disorders represent a heterogeneous group
of genetic diseases characterized by an oxidative-phos-
phorylation (OXPHOS) deficiency. OXPHOS is carried
out by themitochondrial respiratory chain (RC), a complex
pathway linking cellular respiration to the synthesis of
adenosine triphosphate. The RC consists of five complexes
composed of more than 80 distinct subunits, 13 of which
are encoded by mtDNA. Moreover, several hundred
nuclear genes are also needed for various functions of the
RC. OXPHOS deficiency results from either mitochondrial
or nuclear gene mutations.1 Among them, multiple-RC
deficiencies are associated with a variety of disease mecha-
nisms that alter mtDNA maintenance, translation of mito-
chondrially encoded proteins, and cardiolipin synthesis.2
Several point mutations and large deletions of mtDNA
have been shown to cause multiple-RC deficiency.
However, an increasing number of disease mutations are
being identified in this group of mitochondrial diseases.
Almost all of them encode mitochondrial proteins that
are synthesized within the cytosol and further imported
into the mitochondria. Mitochondria import not only
proteins but also a few small RNAs that are essential for
replication, transcription, and translation of the mito-
chondrial genome. Almost all species, including humans,
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critical for mitochondrial translation. Two other RNAs
are imported, and these are (1) MRP RNA (MIM 157660),
a noncoding RNA component of RNase MRP, a site-specific
endoribonuclease involved in primer RNA cleavage during
replication of mtDNA4 and (2) RNase P RNA component
(MIM 608513), thought to participate in the maturation
of mitochondrial tRNA (mt-tRNA). In addition, several
nuclear tRNAs were reportedly targeted to mitochondria
either in vitro5 or in vivo6,7 and were shown to rescue
a mtDNA mutation linked to myoclonic epilepsy associ-
ated with ragged-red fibers (MERFF) syndrome (MIM
545000).8 Finally, several nuclearly encoded miRNAs are
localized in the mitochondria and could represent a new
regulatory pathway for nuclear-mitochondrial cross-talk.9
The way in which these small RNAs are imported into
the mitochondria is not well understood, and various
mechanisms have been considered.3,6,10 Recently, the
mitochondrial protein PNPase has been shown to facilitate
mitochondrial import of 5S rRNA, MRP RNA, and RNaseP
RNA into mammalian cells.11 Here, we report an abnormal
mitochondrial RNA import triggered by a PNPasemutation
as a cause of mitochondrial RC deficiency.
Subject 1, a girl, was born to first-cousin, healthy Moroc-
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Figure 1. Brain MRIs and Sequence Anal-
yses of the Affected Children
(A) Brain MRIs of subjects 1 (S1) and 2 (S2)
at 14 and 3.5 years of age, respectively. The
arrows show hyperintensities in the bilat-
eral putamen and caudate nuclei.
(B) Sequence analysis of exon 13 of PNPT1
(RefSeq accession number NM_033109) in
a control (left) and subject 1 (right). The
arrow indicates the mutation.
(C) Sequence alignment of the PNPase
proteins from human and nonhuman
sources. The asterisk indicates the altered
amino acid.delivery. Her birth weight was 3,470 g, her height was
49 cm, and her occipitofrontal circumference [OFC] was
35.5 cm. She did apparently well in the first months of
life. She could smile and follow with her eyes at the age
of 2 months and acquired head control at the age of
4 months. However, she presented with vomiting, poor
eating, and swallowing difficulties of unexplained origin,
and she could never sit unaided. At 9 months of age, she
suddenly developed trunk hypotonia with disorganized,
asynchronic, and erratic dystonic and choreoathetotic
movements of all four limbs and bucofacial dyskinesias.
She lost purposeful hand movements and could no
longer hold her bottle. When she was first referred, she
was a 10-year-old bed- and wheel-chair-bound, severely
hypotrophic girl (weight ¼ 17 kg [3 standard deviations
(SDs)]; OFC ¼ 49 cm [2.5 SDs]). She could neither stand
nor sit unaided. Her voluntary movements were slow
andmarkedly hampered by dystonia, dyskinesia, and chor-
eoathetosis. She had global hypotonia, severe muscle
weakness, no head control, and permanent bucofacial
dyskinesias. Deep-tendon reflexes of the inferior limbs
were barely detected, owing to muscle atrophy and perma-
nent abnormal movements, but her nerve-conduction
velocity was reduced (32–35 m/s; controls ¼ 40–45 m/s).
She could not speak, but she understood and obeyed
simple orders. She was otherwise fully conscious and alert,The American Journal of Human Genand she could smile, burst out laugh-
ing, and follow with her eyes with
a direct gaze and no abnormal eye
movements. Major swallowing diffi-
culties required gastrostomy, and
major retractions of the right hip
and ankles prompted a consideration
of multiple tenotomies.
The second child (subject 2), a boy,
was also born after a full-term preg-
nancy and normal delivery. His birth
weight was 3,580 g, his height was
50 cm, and his OFC was 36.5 cm. He
also did well in the first few months
of life and could smile and follow
with his eyes, but he never acquired
head control. At 6 months of age, hesuddenly developed motor regression with trunk hypo-
tonia and choreoathetotic movements. He lost the ability
to hold his bottle and grasp. When he was first referred
at 3.5 years old, he had major dystonia of the limbs, global
hypotonia, and permanent choreoathetotic movements
(his weight was 14.6 kg, and his height was 96 cm). All
subject samples were acquired according to the Necker
Hospital Ethical Committee, and informed consent was
given prior to sample collection.
The two affected children therefore had a fixed, severe,
but nonprogressive encephalopathy and mildly elevated
plasma and cerebrospinal-fluid lactate. Brain magnetic
resonance images (MRIs) (axial T2, fast-spin-echo-
weighted images) of the two children showed hyperinten-
sities in the bilateral putamen and caudate nuclei
(Figure 1A). Neither white-matter involvement nor ponto-
cerebellar anomalies were noted. Electroencephalographic
evidence of clinically silent erratic myoclonies was noted.
A severe decrease in the activity of RC complexes III
and IV was found in the liver of subject 1, whereas
normal enzyme-activity values were found in her skeletal
muscle biopsy and in cultured skin fibroblasts of subject
2 (Table 1). Histopathological examination showed pre-
dominant type I fibers, mild atrophy of type II fibers, and
peripheral accumulation of abnormal mitochondria.
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Table 1. Respiratory-Chain Activities in Liver Homogenate, Muscle Mitochondria, and Fibroblasts
Liver Homogenate Muscle Mitochondria Fibroblasts
Subject 1 Control Subject 1 Control Subject 2 Control
Absolute Activity (nmol/min/mg of Protein)
CI 20 25 5 5 108 73 5 15 14 13 5 3
CII 140 1465 20 143 98 5 20 28 21 5 2
CIII 185 4005 60 2,343 1,458 5 257 247 181 5 20
CIV 48 1875 29 1,073 7405 146 132 103 5 11
CV 149 1125 29 539 3355 68 61 65 5 6
CS 48 61 5 9 573 3995 70 75 75 5 7
Activity Ratios
CI/CS 0.41 0.41 5 0.08 0.19 0.18 5 0.02 0.19 0.17 5 0.03
CII/CS 2.93 2.23 5 0.30 0.25 0.25 5 0.02 0.38 0.29 5 0.02
CIII/CS 3.86 6.43 5 0.85 4.09 3.91 5 0.40 3.31 2.53 5 0.20
CIV/CS 0.99 3.03 5 0.38 1.87 1.96 5 0.15 1.77 1.35 5 0.11
CV/CS 3.11 1.80 5 0.34 0.94 0.80 5 0.06 0.27 0.27 5 0.03
Abnormal values are in bold. The following abbreviations are used: CI–CV, complexes I–V; and CS, citrate synthase.common point mutations were excluded by the use of
appropriate techniques in liver DNA of the two children.
Blue-native gel electrophoresis (BN-PAGE) in cultured
skin fibroblasts showed normal RC assembly in subject 2.
To identify the causative nuclear gene mutation, we
sequenced the exomes of subjects 1 and 2. The subjects’
genomic DNA (1 mg) was isolated from blood leukocytes.
We captured exons by the in-solution enrichmentmethod-
ology (SureSelect Human All Exon Kits v.3, Agilent, Massy,
France) by using the company’s biotinylated oligonucleo-
tide probe library (Human All Exon v.3 50 Mb, Agilent).
Each genomic DNA sample was then sequenced on
a sequencer as paired-end 75 bp reads (Illumina HI-
SEQ2000, Illumina, San Diego, USA). Image analyses and
base calling were performed with Real Time Analysis Pipe-
line v.1.9 with default parameters (Illumina). Sequences
were aligned to the human genome reference sequence
(hg19 assembly), and SNPs were called on the basis of
the allele calls and read depth with the use of the CASAVA
(Consensus Assessment of Sequence and Variation 1.8
[Illumina]) pipeline. From the 48,068 and 48,069 SNPs
and indels identified in subjects 1 and 2, respectively,
the pathogenic variant was selected according to the
following criteria. (1) The known SNPs reported in dbSNP,
1000 Genomes, and the Exome Variant Server were
excluded. (2) Intergenic variants were excluded because
most mutations disrupt protein-coding sequences in
Mendelian disorders. (3) Given the consanguinity of
the parents, only homozygous variations were considered.
(4) Finally, variations shared by both subjects 1 and 2 were
selected. This filtering resulted in a list of 25 genes, only
one of which (PNPT1 [MIM 610316]) encodes a known
mitochondrial protein. The homozygous c.1160A>G914 The American Journal of Human Genetics 91, 912–918, Novembmutation in exon 13 of PNPT1 (RefSeq accession number
NM_033109.3) on chromosome 2 resulted in the transition
of a neutral glutamine into a basic arginine (p.Gln387Arg)
in the protein. This change is predicted to be probably
damaging and deleterious by PolyPhen and SIFT software,
respectively. Sanger sequencing allowed us to confirm this
mutation in the two affected individuals (Figure 1B) and
showed that the parents were heterozygous and that the
healthy brother was wild-type (WT) homozygous (not
shown). We then sequenced PNPT1 in a series of nine indi-
viduals with a similar clinical presentation and/or brain
MRI, but we failed to detect any other mutations. Finally,
this mutation was not found in 100 controls of north
African origin. The p.Gln387 substitution lies in a highly
conserved domain of the protein and is present in amino
acid sequences from humans to C. elegans (Figure 1C).
PNPT1 encodes the mitochondrial polynucleotide phos-
phorylase, a 30–50 exoribonuclease and poly-A polymerase
(PNPase) predominantly located in the mitochondrial
intermembrane space.12 This protein assembles into a
homo-oligomeric complex consisting of a trimer or a dimer
of trimers.11 We therefore studied the effect of the PNPT1
mutation on the amount and multimerization of the
PNPase. SDS-PAGE analysis of total-protein extracts from
cultured skin fibroblasts showed a marked decrease in
mutant protein because only 50%–60% of normal PNPase
could be detected in subject 1 compared to the control
(Figure 2A). However, the amounts of PNPT1 transcripts
were similar between the fibroblasts of subject 1 and
control fibroblasts (not shown), suggesting that the
p.Gln387Arg substitution destabilizes the mutant protein.
Proteins (30 mg) solubilized from subject 1 mitoplasts were
loaded on a 4%–16% acrylamide nondenaturing gradienter 2, 2012
Figure 2. PNPase Analysis
(A) SDS-PAGE and immunoblot analysis of PNPase and actin in
subject 1 (S1) and a control (C).
(B) BN-PAGE analysis of mitochondria from cultured skin fibro-
blasts of subject 1 (S1) and a control (C) with PNPase antibodies.
SDHA (complex II) and core 2 (complex III) were used as loading
controls.
Figure 3. Quantification of Mitochondrial Import of 5S rRNA
and MRP RNA by RNA Hybridization
(A) On the left, total and mtRNA from cultured skin fibroblasts of
a control (C) and subject 1 (S1) were separated in denaturing 10%
PAGE, transferred on Hybond-N filters, and hybridized with oligo-
nucleotide-labeled probes for 5S rRNA,mt-tRNAVal, and 5.8S rRNA.
Two deposits (1 and 3 mg) of subject mtRNA were analyzed
for 5S-rRNA-import analysis. In the middle is Northern blot
hybridization with 5S-rRNA-specific, mt-tRNAVal-specific, and
5.8S-rRNA-specific radio-labeled probes of total and mtRNA from
HepG2 cells transfected or not with PNPT1 siRNAs. On the right,
Northern blot analysis of mtRNA after transient expression of
WT PNPT1 cDNA restored both 5S rRNA and 136 bp MRP RNA
amounts in the mitochondria of subject 1 (S1) fibroblasts.
(B) Relative values of 5S rRNA import in subject 1 (S1) fibroblasts
normalized to the control (C). Error bars correspond to two inde-
pendent experiments.
(C) Relative 5S rRNA import and PNPase amount in control HepG2
and treated HepG2þ siRNA cells. The error bars correspond to two
independent experiments. Immunoblot analysis of PNPase down-
regulation is shown in the inset. The actin-specific antibody was
used as a loading control.gel (Invitrogen).13 After electrophoresis, gels were trans-
ferred onto a membrane (GE Healthcare), processed for
immunoblotting, and immunoblotted for PNPase. A
~260 kDa complex containing PNPase was detected in
control fibroblasts and might represent PNPase trimers.
This complex was totally absent from the subjects’
cultured cells, whereas similar amounts of RC complexes
II and III, used as loading tests, were detected in subjects
and controls. No assembly intermediate could be detected
in either subject or control mitoplasts (Figure 2B). The
absence of PNPase complexes in the subjects’ fibroblasts,
despite a residual amount of mutant PNPase, suggests
that the p.Gln387Arg substitution alters multimerization
of the protein, although one cannot exclude that the
mutation affects association with proteins from the mito-
chondrial inner membrane.
So far, the way in which small RNA is imported into
mitochondria has remained poorly understood. However,
it has been recently proposed that PNPase could be
involved in RNA targeting to human mitochondria.11 We
therefore studied the possible impact of the PNPase substi-
tution on mitochondrial RNA import. We isolated total
and mitochondrial RNA (mtRNA) from cultured skin fibro-The Americanblasts of subjects and controls8,14 and analyzed 5S rRNA
import by Northern hybridization by using the following
32P-labeled probes: 50-CATCCAAGTACTACCAGGCCC-30
for 5S rRNA, 50-GGCCGCAAGTGCGTTCGAAG-30 for
5.8S rRNA (control for the absence of cytosolic contamina-
tion), and 50-GTTGAAATCTCCTAAGTG-30 for mt-tRNAVal
(control for the absence of mtRNA degradation during
the procedure). We observed a significant decrease in 5S
rRNA import (70%5 10%) into isolated and cytosol non-
contaminated mitochondria from subject 1 compared to
the control (Figure 3). To model the effect of PNPase
decrease in an independent cell line, we analyzed mito-
chondrial import of 5S rRNA in a human immortalized
HepG2 cell line in the presence of PNPT1 siRNA. HepG2
cells were lipofectamine transfected with a mixture of
three dsRNA duplexes (AAGAGUUACAUCUGAAGUCCU,
AAAACCUCGAGCAUCUAGAAA, and AAAACAGGUGUA
ACUAUUA)15 and analyzed 48 hr after a single transfec-
tion. Immunoblot analyses confirmed efficient knock-
down of PNPT1 given that the amount of PNPase was
reduced by at least three to four times (Figure 3). This
reduction was accompanied by a 50%–60% decrease inJournal of Human Genetics 91, 912–918, November 2, 2012 915
Figure 4. Analysis of MRP RNA
(A) Analysis of MRP RNA isolated from HEK 293 cells. The left
panel shows ethidium-bromide (EtBr)-colored 10% denaturating
polyacrylamide gel. The sizing of tRNA, 5S rRNA, and 5.8S rRNA,
which were used as size markers, was confirmed by hybridization
with corresponding oligonucleotide probes. The right panel shows
a hybridization autoradiograph with MRP-RNA oligonucleotide-
labeled probes of total RNA, total RNA after lysis of cells with
Triton X-100 (1%), crude mtRNA, and mtRNA after mitochondria
were treated with an RNase mixture.
(B) Analysis of mitochondrial import of MRP RNA by RNA hybrid-
ization. In the Northern blot analysis, total and mtRNA from
cultured skin fibroblasts of a control (C) and subject 1 (S1) were
hybridized withMRP-RNA,mt-tRNAVal, and 5.8S rRNA oligonucle-
otide-labeled probes. Full-sized (265 bp) and processed forms of
the MRP RNA (136 bp) are indicated.5S rRNA in mitochondria. Why a three-to-four-times
reduction of PNPase levels only reduced the 5S rRNA
amount by half is questionable, but these results clearly
confirm the importance of PNPase for 5S rRNA import.
MRP RNA is the RNA component of RNase MRP, a site-
specific endoribonuclease involved in primer-RNA
cleavage during the replication of mtDNA.4 MRP RNA is
265 nt long in size. After its PNPase-dependent import
into mitochondria, MRP RNA is believed to be at least
partially processed into a 136 nt molecule containing916 The American Journal of Human Genetics 91, 912–918, Novemba sequence capable of base pairing with a region of its
mtRNA substrate.11,16 Indeed, we detected the processed
form of MRP RNA in RNase-treated mitochondria of
human embryonic kidney (HEK) 293 cells by Northern
blot hybridization by using the 32P-labeled probe 50-
GTGGGAAGCGGGGAATGTCTACG-30 (Figure 4A). Ana-
lyzing control and subject fibroblasts, we found similar
amounts of full-sized MRP RNA in total-RNA preparations
of both subjects and controls. Importantly, however, the
130–140 bp RNA species resulting from MRP-RNA matura-
tion4 was detected in purified mitochondria from control,
but not subject, fibroblasts (Figure 4B). The same amount
of mt-tRNAVal in purified mitochondria from controls
and subjects ruled out RNA degradation. Our results
suggest that mitochondrial import of at least two indepen-
dent RNA species is strongly affected by the PNPT1 muta-
tion in the subjects’ cultured fibroblasts. A decreased
MRP RNA amount has apparently little impact on the level
of mtDNA given that the mtDNA content in the subjects’
fibroblasts was 42% of control values; this is usually
considered normal given the large variability of control
ranges. One can hypothesize that the mitochondrial
import and processing of MRP RNA mostly impact the
switch between asymmetrical and strand-coupled modes
of mtDNA synthesis.17
Finally, considering that import of 5S rRNA has been
shown to play an essential role in mitochondrial transla-
tion,3 we questioned whether mitochondrial protein
synthesis was affected in the subjects’ cells. Pulse-chase
incorporation of 35S-methionine into mitochondrially-
synthesized polypeptides was tested in the presence of
0.5 mg/ml emetine for the inhibition of cytoplasmic trans-
lation.8 To assure correct quantification, we simulta-
neously performed immunoblotting by using an actin
antibody. We found a reproducible mitochondrial-transla-
tion decrease mainly affecting COX subunits in subject,
rather than control, fibroblasts (Figure 5A and C). The
decrease was much less pronounced than that of the 5S
rRNA import (58% 5 4% versus 30% 5 5%), suggesting
that the residual 5S rRNA level was sufficient to ensure
significant mitochondrial translation of RNA. Such a
limited effect was previously observed when 5S rRNA
import was only partially abolished.3 Similarly, knocking
down PNPase in control fibroblasts with the use of
PNPT1-specific siRNAs (as with HepG2 cells, see above) re-
sulted in a translation defect as well (Figure 5A, right
panel). In order to confirm that the translational defect
was due to the PNPase substitution, we transiently trans-
fected subject fibroblasts with WT PNPT1 cDNA expressed
under the control of the CMV promoter (cloned in
pCMV6-XL4 vector, purchased in OriGene). Transient
cDNA expression induced a 160% increase in the PNPase
band intensity 48 hr after transfection (Figure 5). More-
over, an almost full restoration of protein-synthesis rate
was observed (Figure 5). Finally, overexpression of WT
PNPT1 cDNA in subject fibroblasts restored both mito-
chondrial 5S rRNA and 136 bp MRP RNA amountser 2, 2012
Figure 5. Analysis of Mitochondrial Translation in the Subjects
Fibroblasts
(A) In vivo pulse-chase 35S-methionin incorporation in mito-
chondrially synthesized polypeptides in fibroblasts of subject 1
(S1), S1 fibroblasts transiently transfected with WT PNPT1 cDNA
(S1 þ WT PNPT1), control (C) fibroblasts, and control fibroblasts
transfected with PNPT1 siRNAs (C þ siRNA). The mitochondrial-
translation products on 12% SDS-PAGE are indicated according
to the standard pattern.18 The bottom parts (loading control)
show the immunoblot assay with antibodies against actin and
PNPase.
(B) Quantification of the PNPase expression by immunoblot anal-
ysis was performed in parallel with unlabelled aliquots of the same
cell lines.
(C) On the left are relativemitochondrial-translation products and
PNPase levels in subject 1 (S1) fibroblasts, S1 fibroblasts transiently
transfected with WT PNPT1 cDNA (S1 þWT PNPT1), and control
(C) fibroblasts. On the right are relative mitochondrial-translation
products and PNPase levels in control fibroblasts transfected (C þ
siRNA) or not (C) with PNPT1 siRNAs. For both diagrams, error
bars correspond to two independent experiments.(Figure 3A, right panel). These results clearly demonstrate
the deleterious effect of the PNPT1mutation onmitochon-
drial translation and RNA import. It is worth remembering
that although PNPT1 silencing in HeLa cells has failed to
alter the rate of mitochondrial translation,19 a clear defect
in mitochondrial protein synthesis was observed in a liver-
specific knockout of a Pnpt1 mouse model and RNAi in
HEK 293 cells,11 where all mitochondrially-encoded poly-
peptides appeared to be uniformly affected. This apparent
contradiction might be accounted for by HeLa cells’ low
glycolytic metabolism compared to active mitochondrial
respiration in the liver. Also, because PNPase is involved
in various functions such as noncoding RNA import11
and mRNA polyadenylation,15 it should be hypothesized
that different cells or tissues might require different func-
tions of PNPase.The AmericanThe exact function(s) of the human PNPase is not
completely understood. It was found to be active in phos-
phorolysis of RNA, but its localization in the mitochon-
drial intermembrane space (where no RNA is constantly
present) suggests that it is not directly involved in the
metabolism of mtRNA.20 This protein has also been identi-
fied as a T cell leukemia-1 (TCL1) binding partner, whereas
the biological implications of TCL1-PNPase complexes
remain elusive.21 PNPase is also involved in the processing
and adenylation of mitochondrial mRNA,19 but the most
recent data support its crucial role inmitochondrial import
of small RNAs needed for replication, transcription, and
translation of the mitochondrial genome.11
In conclusion, we report here a pathogenic PNPT1muta-
tion in humans. This mutation destabilizes the protein and
abrogates its multimerization. Moreover, we also show that
this mutation alters mitochondrial RNA import and mito-
chondrial translation. These results strongly support the
role of PNPase in the import of RNA into mitochondria
and provide evidence for its crucial importance in main-
taining a functional RC. Impaired RNA import into mito-
chondria therefore represents a disease mechanism in
multiple-RC deficiency. Based on this single family, our
study supports the importance of exome sequencing for
the identification of rare disease-causing gene mutations.Acknowledgments
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